Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of RUVBL2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse |
| Host species | Rabbit |
| Applications | WB |
More info about RUVBL2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB3727 |
| Product name: | RUVBL2 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of RUVBL2. |
| Gene id: | 10856 |
| Gene name: | RUVBL2 |
| Gene alias: | CGI-46|ECP51|INO80J|REPTIN|RVB2|TIH2|TIP48|TIP49B |
| Gene description: | RuvB-like 2 (E. coli) |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human RUVBL2. |
| Protein accession: | NP_006657;Q6FIB9 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse |
| Application image: |  |
| Application image note: | The RUVBL2 polyclonal antibody (Cat # PAB3727) is used in Western blot to detect RUVBL2 in mouse kidney (left) and SK-BR-3 (right) tissue/cell line lysates. |
| Applications: | WB |
| Shipping condition: | Dry Ice |
| Publications: | An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc.Wood MA, McMahon SB, Cole MD. Mol Cell. 2000 Feb;5(2):321-30. |